Association between the preprocedural serum potassium level and atrial fibrillation recurrence after catheter ablation

Abstract

BackgroundThe association between serum potassium and atrial fibrillation (AF) recurrence after catheter ablation remains unclear. ObjectiveThe purpose of this study was to investigate whether preprocedural serum potassium level influences AF recurrence in patients who underwent catheter ablation. MethodsWe used data of patients with AF who underwent de novo catheter ablation from the prospective Chinese Atrial Fibrillation Registry Study. Patients with prior ablation and without baseline serum potassium were excluded. The primary outcome was 1-year AF recurrence after a 3-month blanking period from the ablation procedure. Restricted cubic spline and Cox proportional models were used to compare outcomes across serum potassium groups. ResultsA total of 4838 patients with AF who underwent de novo catheter ablation was enrolled. At 1 year, AF recurrence occurred in 1347 patients (27.8%). The relationship between preprocedural serum potassium levels and 1-year AF recurrence after ablation presented as U shape (P for nonlinear = .048). Compared with the group of serum potassium within 4.41–4.60 mmol/L, the risk of AF recurrence increased significantly in the lowest serum potassium group (≤4.00 mmol/L) after multivariable analysis (hazard ratio [HR] 1.26; 95% confidence interval 1.06–1.51; P = .010). Other groups with lower or higher serum potassium levels including 4.01–4.20 mmol/L (HR 1.18), 4.21–4.40 mmol/L (HR 1.16), 4.61–4.80 mmol/L (HR 1.07), and ≥4.81 mmol/L (HR 1.11) showed nonsignificant higher recurrence risk. ConclusionThe relationship between preprocedural potassium and AF recurrence was U shaped, with an optimal potassium range (4.41–4.60 mmol/L). Lower potassium level is associated with increased AF recurrence risk after catheter ablation.